Brainstem tumors: Current management and future directions

Abstract

Tumors arising in the brainstem comprise 10–20% of all pediatric central nervous system (CNS) tumors and account for a small percentage in adults. The prognosis for these tumors was considered uniformly poor prior to the era of modern neuroimaging and the location was fraught with disaster being considered a ‘no man’s land’ for neurosurgeons. Following the introduction of advanced imaging modalities and neurophysiological monitoring, striking progress has occurred in the management of these lesions. Brainstem tumors are presently classified based on their anatomic location, focality, and histopathology. This article reviews the current classification of brainstem tumors, current management options, and future directions in the treatment for these rare tumors.

Key words

Brainstem glioma - brainstem tumors - cervicomedullary - dorsal exophytic tumors - management - medulla - midbrain tumors - pontine glioma - tectal tumors

• References

• 1 Zhang C, Yao Y, Wang Y, Chen Z, Wu J, Mao Y. etal Temozolomide for adult brain stem glioblastoma: Case report of a long-term survivor. Int J Neurosci 2010; 120: 787-791
• 2 Guy G, Jan M, Guegan Y, Aubin ML, Fischer C, Ben-Hassel M. et al [Surgical lesions of the brain stem]. Neurochirurgie 1989; 35 (Suppl. 01) 1-133
• 3 Allen J. Brain stem glioma. Neurol Neurosurg Update Series 1983; 4: 2-7
• 4 Walker DA, Punt JA, Sokal M. Clinical management of brainstem glioma. Arch Dis Child 1999; 80: 558-564
• 5 Berger MS, Edwards MS, La Masters D, Davis RL, Wilson CB. Pediatric brain stem tumors: Radiographic, pathological, and clinical correlations. Neurosurgery 1983; 12: 298-302
• 6 Littman P, Jarrett P, Bilaniuk LT, Rorke LB, Zimmerman RA, Bruce DA. et al Pediatric brain stem gliomas. Cancer 1980; 45: 2787-2792
• 7 Fulton DS, Levin VA, Wara WM, Edwards MS, Wilson CB. Chemotherapy of pediatric brain-stem tumors. J Neurosurg 1981; 54: 721-725
• 8 Albright AL, Pollack IF. Brainstem gliomas. In: Winn HR. editor Youmans Neurological Surgery. Vol. 3. 5^th ed Philadelphia: Saunders; 2004. p 3663-3669
• 9 Recinos PF, Sciubba DM, Jallo GI. Brainstem tumors: Where are we today?. Pediatr Neurosurg 2007; 43: 192-201
• 10 Weiner HL, Freed D, Woo HH, Rezai AR, Kim R, Epstein FJ. Intra-axial tumors of the cervicomedullary junction: Surgical results and longterm outcome. Pediatr Neurosurg 1997; 27: 12-18
• 11 Epstein F, Wisoff JH. Intrinsic brainstem tumors in childhood: Surgical indications. J Neurooncol 1988; 6: 309-317
• 12 Hoffman HJ, Becker L, Craven MA. A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 1980; 7: 243-248
• 13 Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP, Davidson G. Transependymal benign dorsally exophytic brain stem gliomas in childhood: Diagnosis and treatment recommendations. Neurosurgery 1987; 20: 439-444
• 14 Alvisi C, Cerisoli M, Maccheroni ME. Long-term results of surgically treated brainstem gliomas. Acta Neurochir (Wien) 1985; 76: 12-17
• 15 Epstein F, McCleary EL. Intrinsic brain-stem tumors of childhood: Surgical indications. J Neurosurg 1986; 64: 11-15
• 16 Epstein F. A staging system for brain stem gliomas. Cancer 1985; 56 (07) Suppl 1804-1806
• 17 Barkovich AJ, Krischer J, Kun LE, Packer R, Zimmerman RA, Freeman CR. et al Brain stem gliomas: A classification system based on magnetic resonance imaging. Pediatr Neurosurg 1990; 16: 73-83
• 18 Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ. Radiologic classification of brain stem tumors: Correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996; 24: 9-23
• 19 Albright AL. Brain stem gliomas. In: J Y, editor Neurological Surgery. Philadelphia: Saunders; 1996. p 2603-2611
• 20 Dechambre S, Duprez T, Lecouvet F, Raftopoulos C, Gosnard G. Diffusion-weighted MRI postoperative assessment of an epidermoid tumour in the cerebellopontine angle. Neuroradiology 1999; 41: 829-831
• 21 Murakami N, Matsushima T, Kuba H, Ikezaki K, Morioka T, Mihara F. et al Combining steady-state constructive interference and diffusion-weighted magnetic resonance imaging in the surgical treatment of epidermoid tumors. Neurosurg Rev 1999; 22: 159-162
• 22 Recinos PF, Roonprapunt C, Jallo GI. Intrinsic brainstem epidermoid cyst. Case report and review of the literature. J Neurosurg 2006; 104 (04) Suppl 285-289
• 23 Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: A report from the Children’s Cancer Group. Neurosurgery 1993; 33: 1026-1029 ; discussion 1029-1030
• 24 Jallo GI, Biser-Rohrbaugh A, Freed D. Brainstem gliomas. Childs Nerv Syst 2004; 20: 143-153
• 25 Choux M, Lena G, Do L. Brainstem tumors. In: Choux M, Di Rocco C, Hockley A. editors Pediatric Neurosurgery. New York: Churchill Livingstone; 2000. p 471-491
• 26 Albright AL, Guthkelch AN, Packer RJ, Price RA, Rourke LB. Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 1986; 65: 751-755
• 27 Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME. et al There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a Pediatric Oncology Group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys Mar 1999; 43: 959-964
• 28 Epstein FJ, Farmer JP. Brain-stem glioma growth patterns. J Neurosurg 1993; 78: 408-412
• 29 Morota N, Deletis V. The importance of brainstem mapping in brainstem surgical anatomy before the fourth ventricle and implication for intraoperative neurophysiological mapping. Acta Neurochir (Wien) 2005; 148: 499-509
• 30 Morota N, Deletis V, Lee M, Epstein FJ. Functional anatomic relationship between brain-stem tumors and cranial motor nuclei. Neurosurgery 1996; 39: 787-793 ; discussion 793-784
• 31 Morota N, Deletis V, Epstein FJ, Kofler M, Abbott R, Lee M. et al Brain stem mapping: Neurophysiological localization of motor nuclei on the floor of the fourth ventricle. Neurosurgery 1995; 37: 922-929 discussion 929-30
• 32 Sala F, Krzan MJ, Deletis V. Intraoperative neurophysiological monitoring in pediatric neurosurgery: Why when, how?. Childs Nerv Syst 2002; 18: 264-287
• 33 Bricolo A. Surgical management of intrinsic brain stem gliomas. Oper Tech Neurosurg 2000; 3: 137-154
• 34 Abbott R. Tumors of the medulla. Neurosurg Clin N Am 1993; 4: 519-527
• 35 Jallo GI, Kothbauer KF, Epstein FJ. Surgical Management of Cervicomedullary and Dorsally Exophytic Brain Stem Tumors. Oper Tech Neurosurg 2000; 3: 131-136
• 36 Pollack IF, Hoffman HJ, Humphreys RP, Becker L. The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993; 78: 859-863
• 37 Epstein F, Wisoff J. Intra-axial tumors of the cervicomedullary junction. J Neurosurg 1987; 67: 483-487
• 38 Abbott R, Shiminski-Maher T, Epstein FJ. Intrinsic tumors of the medulla: Predicting outcome after surgery. Pediatr Neurosurg 1996; 25: 41-44
• 39 Abbott R, Shiminski-Maher T, Wisoff JH, Epstein FJ. Intrinsic tumors of the medulla: Surgical complications. Pediatr Neurosurg 1991; 17: 239-244
• 40 Shiminski-Maher T. Brainstem tumors in childhood: Preparing patients and families for long- and short-term care. Pediatr Neurosurg 1996; 24: 267-271
• 41 Jallo GI, Shiminski-Maher T, Velazquez L, Abbott R, Wisoff J, Epstein F. Recovery of lower cranial nerve function after surgery for medullary brainstem tumors. Neurosurgery 2005; 56: 74-77 ; discussion 78
• 42 Shiminski-Maher T, Abbott R, Wisoff JH, Epstein FJ. Current trends in the management of brainstem tumors in childhood. J Neurosci Nurs 1991; 23: 356-362
• 43 Li KW, Roonprapunt C, Lawson HC, Abbott IR, Wisoff J, Epstein F. et al Endoscopic third ventriculostomy for hydrocephalus associated with tectal gliomas. Neurosurg Focus 2005; 18: E2
• 44 Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB. et al Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy, A Childrens Cancer Group Phase I/II Trial. Cancer 1994; 74: 1827-1834
• 45 Robertson PL, Allen JC, Abbott IR, Miller DC, Fidel J, Epstein FJ. Cervicomedullary tumors in children: A distinct subset of brainstem gliomas. Neurology 1994; 44: 1798-1803
• 46 Allen JC, Siffert J. Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg 1996; 24: 98-102
• 47 Nelson Jr MD, Soni D, Baram TZ. Necrosis in pontine gliomas: Radiation induced or natural history?. Radiology 1994; 191: 279-282
• 48 Packer RJ, Zimmerman RA, Kaplan A, Wara WM, Rorke LB, Selch M. et al Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Data from the Childrens Cancer Group. Cancer 1993; 71: 2666-2674
• 49 Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994; 91: 2076-2080
• 50 Groothuis DR, Ward S, Itskovich AC, Dobrescu C, Allen CV, Dills C. et al Comparison of 14C-sucrose delivery to the brain by intravenous intraventricular, and convection-enhanced intracerebral infusion. J Neurosurg 1999; 90: 321-331
• 51 Occhiogrosso G, Edgar MA, Sandberg DI, Souweidane MM. Prolonged convection-enhanced delivery into the rat brainstem. Neurosurgery 2003; 52: 388-394
• 52 Lee J, Jallo GI, Guarnieri M, Carson Sr BS, Penno MB. A novel brainstem tumor model: Guide screw technology with functional, radiological, and histopathological characterization. Neurosurg Focus 2005; 18: E11
• 53 Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI. Treatment of diffuse intrinsic brainstem gliomas: Failed approaches and future strategies. J Neurosurg Pediatr 2009; 3: 259-269
• 54 Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM. et al Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Gene Ther 2002; 9: 1653-1658
• 55 Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB. et al Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Cancer Gene Ther 2002; 9: 87-95
• 56 Todo T, Rabkin SD, Martuza RL. Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors. Cancer Gene Ther 2000; 7: 939-946
• 57 De Bouard S, Guillamo JS, Christov C, Lefévre N, Brugières P, Gola E. et al Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin. Hum Gene Ther 2003; 14: 883-895
• 58 Ruan S, Okcu MF, Pong RC, Andreeff M, Levin V, Hsieh JT. et al Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Clin Cancer Res 1999; 5: 197-202
• 59 Miller CR, Williams CR, Buchsbaum DJ, Gillespie GY. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Cancer Res 2002; 62: 773-780
• 60 Yamanaka R, Yajima N, Tsuchiya N, Honma J, Tanaka R, Ramsey J. et al Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA. J Neurosurg 2002; 97: 1184-1190
• 61 Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S. et al Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci U S A 2005; 102: 14344-14349